VSAR
Versartis

2,816
Loading...
Loading...
Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14

Frequently Asked Questions

What is Market Cap of Aravive Inc?
What is the 52-week high for Aravive Inc?
What is the 52-week low for Aravive Inc?
What is Aravive Inc stock price today?
What was Aravive Inc stock price yesterday?
What is the PE ratio of Aravive Inc?
What is the Price-to-Book ratio of Aravive Inc?
What is Aravive Inc's EBITDA?
What is the 50-day moving average of Aravive Inc?
How many employess does Aravive Inc has?

Latest VSAR News

View
No VSAR news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.